135 related articles for article (PubMed ID: 1982489)
1. Enantiomers of 8-(3-tert-butylamino-2-hydroxypropoxy)-3,4-dihydro-3-oxo-2H- (1,4)benzothiazine: racemic resolution, chiral synthesis and biological activity.
Schiaffella F; Fringuelli R; Cecchetti V; Fravolini A; Angeli P; Marucci G
Farmaco; 1990 Dec; 45(12):1299-307. PubMed ID: 1982489
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and alpha,beta-adrenergic blocking potency of 2,3-dihydro-1,4-benzodioxin derivatives. (I).
Khouili M; Guillaumet G; Coudert G; Pujol MD
Farmaco; 1996 Mar; 51(3):175-84. PubMed ID: 8688139
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and beta-adrenergic blocking activity of oxipropanolamines of 3,4-dihydro-3-oxo-2H(1,4)benzothiazine.
Cecchetti V; Fravolini A; Fringuelli R; Schiaffella F; Mascellani G; Pagella PG; Rugarli PL
Farmaco Sci; 1987 Jan; 42(1):61-75. PubMed ID: 2898382
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and alpha,beta-adrenergic blocking potency of 2,3-dihydro-1,4-benzodioxin derivatives. (II).
Khouili M; Guillaumet G; Coudert G; Pujol MD
Farmaco; 1996 Mar; 51(3):185-8. PubMed ID: 8688140
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of the new alpha- and beta-adrenergic antagonist 1-[1-(2-benzodioxanylmethyl)-4-piperidyl]amino-3-(1-naphthoxy)-2- propanol.
Mauleón D; Antúnez S; Rosell G
Farmaco; 1989 Nov; 44(11):1109-17. PubMed ID: 2577151
[TBL] [Abstract][Full Text] [Related]
6. Derivatives related to betaxolol with alpha- and beta-adrenergic activities.
Leclerc G; Decker N; Schwartz J
Arzneimittelforschung; 1985; 35(9):1357-67. PubMed ID: 2867769
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and adrenergic properties of new duplicated analogs of methoxamine.
Perez F; Rosell G; Mauleon D; Carganico G
Farmaco; 1991 Oct; 46(10):1155-66. PubMed ID: 1687722
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, absolute configuration, and biological profile of the enantiomers of trans-[2-(2,6-dimethoxyphenoxy)ethyl] [(3-p-tolyl-2,3-dihydro-1,4-benzodioxin-2-yl)methyl]amine (mephendioxan), a potent competitive alpha 1A-adrenoreceptor antagonist.
Quaglia W; Pigini M; Tayebati SK; Piergentili A; Giannella M; Leonardi A; Taddei C; Melchiorre C
J Med Chem; 1996 May; 39(11):2253-8. PubMed ID: 8667368
[TBL] [Abstract][Full Text] [Related]
9. Evidence for adrenergic and tachykinin activity in venom of the stonefish (Synanceja trachynis).
Hopkins BJ; Hodgson WC; Sutherland SK
Toxicon; 1996 May; 34(5):541-54. PubMed ID: 8783449
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and pharmacological evaluation of novel potential ultrashort-acting beta-blockers.
Mokrý P; Zemanová M; Csöllei J; Racanská E; Tumová I
Pharmazie; 2003 Jan; 58(1):18-21. PubMed ID: 12622246
[TBL] [Abstract][Full Text] [Related]
11. A new beta 2-adrenoceptor agonist with alpha 1-adrenoceptor blocking properties.
Olsson OA; Ahlquist B; Gustafsson B
Acta Pharmacol Toxicol (Copenh); 1981 Apr; 48(4):340-8. PubMed ID: 6121453
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological properties of an extremely selective beta 1-adrenoceptor antagonist, 2-[4-[3-(tert-Butylamino)-2-hydroxypropoxy] phenyl]-3-methyl-6-methoxy-4(3H)-quinazolinone [+/-)HX-CH 44 BS).
Daemmgen JW; Engelhardt G; Pelzer H
Arzneimittelforschung; 1985; 35(1A):383-90. PubMed ID: 2859033
[TBL] [Abstract][Full Text] [Related]
13. New 2-substituted 2,3,3a,4-tetrahydro-1H-imidazo[5,1-c] [1,4]benzoxazin-1-ones as alpha 2-adrenoceptor antagonists.
Melloni P; Banzatti C; Heidempergher F; Marazzi G; Ricciardi S; Vaghi F; Varasi M
Farmaco; 1991 Sep; 46(9):1011-21. PubMed ID: 1687241
[TBL] [Abstract][Full Text] [Related]
14. Lack of stereoselectivity in the inotropic and phosphodiesterase inhibitory effects of saterinone enantiomers.
Armah BI; Muster D; Raap A; Brückner R; Graziadei I
Arzneimittelforschung; 1989 Nov; 39(11):1384-92. PubMed ID: 2559738
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological profile of the enantiomers of [4-(4-amino-6,7-dimethoxyquinazolin-2-yl)-cis-octahydroquinoxalin- 1-yl]furan-2-ylmethanone (cyclazosin), a potent competitive alpha 1B- adrenoceptor antagonist.
Giardinà D; Crucianelli M; Romanelli R; Leonardi A; Poggesi E; Melchiorre C
J Med Chem; 1996 Nov; 39(23):4602-7. PubMed ID: 8917649
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological profile of a new beta-adrenoceptor blocker, 4-[3-(tert-butylamino)-2-hydroxypropoxy]-N-methylisocarbostyril hydrochloride (N-696).
Nakagawa Y; Sugai T; Chin WP; Shibuya T; Hashimoto K; Imai S
Arzneimittelforschung; 1984; 34(2):194-9. PubMed ID: 6144313
[TBL] [Abstract][Full Text] [Related]
17. 1,4-Benzodioxanes as reversible and irreversible antagonists at adrenergic receptors.
Avner BP; Triggle DJ
J Med Chem; 1974 Feb; 17(2):197-200. PubMed ID: 4148932
[No Abstract] [Full Text] [Related]
18. 1,3-dioxolane-based ligands as a novel class of alpha1-adrenoceptor antagonists.
Brasili L; Sorbi C; Franchini S; Manicardi M; Angeli P; Marucci G; Leonardi A; Poggesi E
J Med Chem; 2003 Apr; 46(8):1504-11. PubMed ID: 12672251
[TBL] [Abstract][Full Text] [Related]
19. Adrenoceptor blocking properties of the stereoisomers of amosulalol (YM-09538) and the corresponding desoxy derivative (YM-11133).
Honda K; Takenaka T; Miyata-Osawa A; Terai M
J Pharmacol Exp Ther; 1986 Mar; 236(3):776-83. PubMed ID: 2869143
[TBL] [Abstract][Full Text] [Related]
20. Structure-activity relationships in 1,4-benzodioxan-related compounds. 2. Role of the amine function on alpha-adrenoreceptor blocking activity.
Giardinà D; Gulini U; Pigini M; Piloni MG; Melchiorre C
Farmaco; 1990 Dec; 45(12):1289-98. PubMed ID: 1982488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
